Literature DB >> 27649959

[Periprosthetic infections in patients with rheumatism : A challenge].

J Fussi1, C Perka2, L Renner1.   

Abstract

The increasing number of implantations will lead to more periprosthetic infections. Periprosthetic infections in patients with rheumatism, who are often undergoing immunosuppressive treatment, represent a challenge for the treating physicians. The optimal care and treatment therefore necessitate an interdisciplinary agreement between orthopedic surgeons, specialists for infections and rheumatologists.

Entities:  

Keywords:  Immunosuppressive therapy; Infection; Rheumatoid arthritis; Rheumatology; Risc factor; Total joint arthroplasty

Mesh:

Substances:

Year:  2016        PMID: 27649959     DOI: 10.1007/s00393-016-0204-1

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  34 in total

1.  New definition for periprosthetic joint infection.

Authors: 
Journal:  J Arthroplasty       Date:  2011-12       Impact factor: 4.757

2.  Diagnosis of periprosthetic joint infection.

Authors:  Benjamin Zmistowski; Craig Della Valle; Thomas W Bauer; Konstantinos N Malizos; Abbas Alavi; Hani Bedair; Robert E Booth; Peter Choong; Carl Deirmengian; Garth D Ehrlich; Anil Gambir; Ronald Huang; Yair Kissin; Hideo Kobayashi; Naomi Kobayashi; Veit Krenn; Drago Lorenzo; S B Marston; Geert Meermans; Javier Perez; J J Ploegmakers; Aaron Rosenberg; Peter Thomas; Stephan Tohtz; Jorge A Villafuerte; Peter Wahl; Frank-Christiaan Wagenaar; Eivind Witzo
Journal:  J Orthop Res       Date:  2014-01       Impact factor: 3.494

Review 3.  Treating periprosthetic joint infections as biofilms: key diagnosis and management strategies.

Authors:  Alice Tzeng; Tony H Tzeng; Sonia Vasdev; Kyle Korth; Travis Healey; Javad Parvizi; Khaled J Saleh
Journal:  Diagn Microbiol Infect Dis       Date:  2014-11-05       Impact factor: 2.803

4.  Oral carriage of staphylococci in patients with rheumatoid arthritis.

Authors:  M S Jackson; J Bagg; M N Gupta; R D Sturrock
Journal:  Rheumatology (Oxford)       Date:  1999-06       Impact factor: 7.580

5.  Outcome of prosthetic joint infection in patients with rheumatoid arthritis: the impact of medical and surgical therapy in 200 episodes.

Authors:  Elie F Berbari; Douglas R Osmon; Mary C T Duffy; R N William Harmssen; Jayawant N Mandrekar; Arlen D Hanssen; James M Steckelberg
Journal:  Clin Infect Dis       Date:  2005-12-06       Impact factor: 9.079

Review 6.  Risk factors for periprosthetic joint infection after total joint arthroplasty: a systematic review and meta-analysis.

Authors:  Y Zhu; F Zhang; W Chen; S Liu; Q Zhang; Y Zhang
Journal:  J Hosp Infect       Date:  2014-12-04       Impact factor: 3.926

7.  Incidence and risk factors of prosthetic joint infection after total hip or knee replacement in patients with rheumatoid arthritis.

Authors:  Tim Bongartz; Christine S Halligan; Douglas R Osmon; Megan S Reinalda; William R Bamlet; Cynthia S Crowson; Arlen D Hanssen; Eric L Matteson
Journal:  Arthritis Rheum       Date:  2008-12-15

Review 8.  Prevention and treatment of Staphylococcus aureus biofilms.

Authors:  Mohini Bhattacharya; Daniel J Wozniak; Paul Stoodley; Luanne Hall-Stoodley
Journal:  Expert Rev Anti Infect Ther       Date:  2015-11-13       Impact factor: 5.091

9.  The Alpha-defensin Test for Periprosthetic Joint Infection Responds to a Wide Spectrum of Organisms.

Authors:  Carl Deirmengian; Keith Kardos; Patrick Kilmartin; Simmi Gulati; Patrick Citrano; Robert E Booth
Journal:  Clin Orthop Relat Res       Date:  2015-07       Impact factor: 4.176

10.  Diagnosing periprosthetic joint infection: has the era of the biomarker arrived?

Authors:  Carl Deirmengian; Keith Kardos; Patrick Kilmartin; Alexander Cameron; Kevin Schiller; Javad Parvizi
Journal:  Clin Orthop Relat Res       Date:  2014-11       Impact factor: 4.176

View more
  1 in total

1.  [Infected endoprosthesis in patients with rheumatism].

Authors:  Markus Weber; M Meyer; J Grifka
Journal:  Z Rheumatol       Date:  2021-04-22       Impact factor: 1.372

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.